Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obsessive-compulsive disorder.

T R Insel

    The Psychiatric Clinics of North America
    |March 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Obsessive-compulsive disorder (OCD) presents distinct anxiety and affective features, differing from compulsive personality traits. Clomipramine effectively treats OCD, serving as a primary or adjunctive therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Understanding how non-coding genomic polymorphisms affect gene expression.

    Molecular psychiatry·2016
    Same author

    Oxytocin and the neurobiology of attachment.

    The Behavioral and brain sciences·2014
    Same author

    Brain somatic mutations: the dark matter of psychiatric genetics?

    Molecular psychiatry·2013
    Same author

    Innovative solutions to novel drug development in mental health.

    Neuroscience and biobehavioral reviews·2013
    Same author

    Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?

    Molecular psychiatry·2012
    Same author

    A bridge to somewhere.

    Translational psychiatry·2012
    Same journal

    Digital Mental Health: Progress but not Perfection.

    The Psychiatric clinics of North America·2026
    Same journal

    Advances in Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    The Future of Digital Mental Health: A Literature Review.

    The Psychiatric clinics of North America·2026
    Same journal

    Assessment and Treatment of Posttraumatic Stress Disorder via Digital Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    Treatment of Obsessive-Compulsive Disorder via Mental Health Technology.

    The Psychiatric clinics of North America·2026
    Same journal

    Digital Mental Health Treatments for Depression.

    The Psychiatric clinics of North America·2026
    See all related articles

    Area of Science:

    • Psychiatry and Behavioral Sciences
    • Neuroscience

    Background:

    • Obsessive-compulsive disorder (OCD) is a complex condition with overlapping features of anxiety and mood disorders.
    • It is phenotypically and epidemiologically distinct from compulsive personality traits.
    • Current understanding of OCD's biological underpinnings, including genetic and neuropsychological factors, remains incomplete.

    Purpose of the Study:

    • To investigate the therapeutic efficacy of clomipramine in treating obsessive-compulsive disorder.
    • To evaluate clomipramine as both a standalone treatment and an adjunct to behavioral therapy for OCD.

    Main Methods:

    • The study focuses on the clinical application of clomipramine, a tricyclic antidepressant.
    • Treatment outcomes were assessed in patients with obsessive-compulsive disorder.

    Related Experiment Videos

    Main Results:

    • Clomipramine demonstrated significant utility in managing symptoms of obsessive-compulsive disorder.
    • The medication proved effective when used as a primary treatment for individuals unresponsive to behavioral interventions.
    • It also served as a valuable adjunct to behavior therapy.

    Conclusions:

    • Clomipramine is a viable and effective pharmacological option for treating obsessive-compulsive disorder.
    • The findings support the use of clomipramine in diverse patient populations with OCD, including those who do not benefit from behavioral approaches alone.